S'abonner

Cumulative effect of evidence-based practices on outcomes of preterm infants born at <29 weeks’ gestational age - 28/01/20

Doi : 10.1016/j.ajog.2019.08.058 
Angelo Rizzolo, BSc a, Prakesh S. Shah, MD b, Isabelle Boucorian, MD c, Brigitte Lemyre, MD d, Valerie Bertelle, MD e, Ermelinda Pelausa, MD f, Marie St Hilaire, MD g, Leanne Dahlgren, MD h, Marc Beltempo, MD a,
on behalf of the

Canadian Neonatal Network and Canadian Preterm Birth Network Investigators

a Department of Pediatrics, Montreal Children’s Hospital–McGill University Health Centre, Montreal, QC, Canada 
b Department of Pediatrics, Mount Sinai Hospital and University of Toronto, Toronto, ON, Canada 
c Department of Obstetrics-Gynecology, Centre Hospitalier Universitaire Sainte-Justine, Montreal, QC, Canada 
d Division of Neonatology, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada 
e Department of Pediatrics, University of Sherbrooke, Sherbrooke, QC, Canada 
f Department of Neonatology, Jewish General Hospital, Montreal, QC, Canada 
g Department of Pediatrics, Maisonneuve Rosemont Hospital, Montreal, QC, Canada 
h Division of Maternal-Fetal Medicine, British Columbia Women’s Hospital, Vancouver, BC, Canada 

Corresponding author: Marc Beltempo, MD.

Abstract

Background

Extremely preterm infants born at <29 weeks’ gestational age are at high risk of death or severe neurological injury. Several individual evidence-based practices have been associated with neuroprotection.

Objective

The objective of the study was to investigate the cumulative effect of 4 evidence-based practices and their association with death and/or severe neurological injury among infants born at <29 weeks’ gestational age.

Study Design

Observational study of infants born at 230–286 weeks gestational age admitted to neonatal intensive care units participating in the Canadian Neonatal Network from 2015 through 2017. We evaluated 4 practices: antenatal corticosteroids, antenatal MgSO4 for neuroprotection, deferred cord clamping ≥30 seconds, and normothermia on admission. The effect of exposure to 1, 2, 3, and all 4 evidence-based practices compared with none on death and/or severe neurological injury was assessed using multivariable logistic regression models adjusted for patient characteristics.

Results

Rate of death and/or severe neurological injury was 20% (873 of 4297) and varied based on exposure to evidence-based practices: none, 34% (54 of 157); 1, 27% (171 of 626); 2, 20% (295 of 1448); 3, 18% (263 of 1448); and all 4, 14% (90 of 618). Significantly lower odds of death and/or severe neurological injury were observed with exposure to antenatal corticosteroids (adjusted odds ratio, 0.52, 95% confidence interval, 0.40–0.69) and deferred cord clamping (adjusted odds ratio, 0.81, 95% confidence interval, 0.68-0.96) but not MgSO4 (adjusted odds ratio, 0.88, 95% confidence interval, 0.72–1.08) or normothermia (adjusted odds ratio, 0.96, 95% confidence interval, 0.79–1.16). Infants exposed to ≥2 evidence-based practices had significantly lower odds of death and/or severe neurological injury than those exposed to no evidence-based practices (adjusted odds ratio, 0.61, 95% confidence interval, 0.43–0.88).

Conclusion

Among infants born at <29 weeks’ gestational age, exposure to at least 2 of the evidence-based practices assessed was associated with decreased odds of death and/or severe neurological injury.

Le texte complet de cet article est disponible en PDF.

Key words : death, evidence-based practices, neuroprotection, preterm, severe neurological injury


Plan


 Although no specific funding has been received for this study, organizational support for the Canadian Neonatal Network was provided by the Maternal-Infant Care Research Centre (MiCare) at Mount Sinai Hospital in Toronto, Ontario, Canada. MiCare is supported by a Canadian Institutes of Health Research team grant (CTP 87518), the Ontario Ministry of Health, and individual participating centers. Dr Shah holds an Applied Research Chair in Reproductive and Child Health Services and Policy Research awarded by the Canadian Institutes of Health Research (APR-126340). The funding agencies had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
 Dr Shah holds an Applied Research Chair in Reproductive and Child Health Services and Policy Research awarded by the Canadian Institutes of Health Research. The other authors report no conflict of interest.
 Cite this article as: Rizzolo A, Shah PS, Boucorian I, et al. Cumulative effect of evidence-based practices on outcomes of preterm infants born at <29 weeks’ gestational age. Am J Obstet Gynecol 2020;222:181.e1-10.


© 2019  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 222 - N° 2

P. 181.e1-181.e10 - février 2020 Retour au numéro
Article précédent Article précédent
  • Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum
  • Lisa C. Zuckerwise, Amanda M. Craig, JM. Newton, Shillin Zhao, Kelly A. Bennett, Marta A. Crispens
| Article suivant Article suivant
  • The duration of fetal antenatal steroid exposure determines the durability of preterm ovine lung maturation
  • Matthew W. Kemp, Masatoshi Saito, Augusto F. Schmidt, Haruo Usuda, Shimpei Watanabe, Shinichi Sato, Takushi Hanita, Yusaku Kumagai, Tsukasa Takahashi, Gabrielle C. Musk, Lucy Furfaro, Lisa Stinson, Erin L. Fee, Peter J. Eddershaw, Matthew S. Payne, Kiara Smallwood, James Bridges, John P. Newnham, Alan H. Jobe

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.